We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00111319
Recruitment Status : Completed
First Posted : May 20, 2005
Last Update Posted : March 26, 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by:
Millennium Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2007
  Study Completion Date : No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):